RAPT Therapeutics, Inc. (RAPT)

Total Valuation

RAPT has a market cap or net worth of $158.08 million. The enterprise value is -$17.36 million.

Market Cap	158.08M
Enterprise Value	-17.36M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPT has 16.54 million shares outstanding. The number of shares has increased by 121.10% in one year.

Current Share Class	16.54M
Shares Outstanding	16.54M
Shares Change (YoY)	+121.10%
Shares Change (QoQ)	+361.39%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	37.23%
Float	6.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.89
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.02.

Current Ratio	21.11
Quick Ratio	20.66
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -75.60% and return on invested capital (ROIC) is -48.23%.

Return on Equity (ROE)	-75.60%
Return on Assets (ROA)	-44.72%
Return on Invested Capital (ROIC)	-48.23%
Return on Capital Employed (ROCE)	-68.67%
Revenue Per Employee	n/a
Profits Per Employee	-$1.71M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.12% in the last 52 weeks. The beta is -0.14, so RAPT's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	-63.12%
50-Day Moving Average	7.49
200-Day Moving Average	10.53
Relative Strength Index (RSI)	61.95
Average Volume (20 Days)	86,156

Short Selling Information

The latest short interest is 6.01 million, so 36.34% of the outstanding shares have been sold short.

Short Interest	6.01M
Short Previous Month	5.01M
Short % of Shares Out	36.34%
Short % of Float	97.06%
Short Ratio (days to cover)	5.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-122.85M
Pretax Income	-120.43M
Net Income	-116.51M
EBITDA	-121.71M
EBIT	-122.85M
Earnings Per Share (EPS)	-$10.97

Balance Sheet

The company has $179.28 million in cash and $3.84 million in debt, giving a net cash position of $175.44 million or $10.61 per share.

Cash & Cash Equivalents	179.28M
Total Debt	3.84M
Net Cash	175.44M
Net Cash Per Share	$10.61
Equity (Book Value)	177.37M
Book Value Per Share	10.75
Working Capital	174.52M

Cash Flow

In the last 12 months, operating cash flow was -$108.63 million and capital expenditures -$60,000, giving a free cash flow of -$108.69 million.

Operating Cash Flow	-108.63M
Capital Expenditures	-60,000
Free Cash Flow	-108.69M
FCF Per Share	-$6.57

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-121.10%
Shareholder Yield	-121.10%
Earnings Yield	-73.70%
FCF Yield	-68.75%

Analyst Forecast

The average price target for RAPT is $42.00, which is 339.33% higher than the current price. The consensus rating is "Buy".

Price Target	$42.00
Price Target Difference	339.33%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-53.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2